DSI Announces Virtual Attendance of BIO Europe Spring 2022, March 28-31

DSI Announces Virtual Attendance of BIO Europe Spring 2022, March 28-31

DSI plans to attend the 2022 BIO Europe Spring conference virtually. Our new Director of Business Development, Ben Luts, will be joining the conference on behalf of DSI. To set up a meeting with Ben, contact him at bluts@dsinpharmatics.com or through the partnering site.

Whether you’ve used our services in the past, need them now, or may require them in the future, we would love to hold a brief meeting with you to introduce you to what DSI offers, catch you up on our new service additions, or learn about your project! Ben and the DSI team are available to meet before, during, or after the conference.

About DSI

DSI is a full-service regulatory drug development consulting firm for pharmaceuticals, biologics and new drug and delivery platforms. DSI provides regulatory, technical, and project management consulting services to healthcare product companies that manufacture and/or market pharmaceuticals, biopharmaceuticals, and next generation therapy products.

Since 2007 we have provided our clients with innovative strategies and exceptional quality work products intended to enhance product development, approval, and marketing presence.

Whether advocating CMC strategy, directing CMC operations or developing CMC submission content that represent the best interests of emerging biotech, we focus on the critical CMC issues and build programs that enhance development.

Connect with DSI on LinkedIn or visit www.dsinpharmatics.com for more information. 

Meranda Parascandola
Head of Business Development and Marketing

Design Space InPharmatics, llc. (DSI)
Tel: (855) 805-8402×104